POINT: Does Persistent or Worsening ARDS Refractory to Optimized Ventilation and Proning Deserve a Trial of Prostacyclin? Yes. [electronic resource]
- Chest 04 2019
- 662-665 p. digital
Publication Type: Editorial; Video-Audio Media
1931-3543
10.1016/j.chest.2018.11.018 doi
Epoprostenol--therapeutic use Humans Platelet Aggregation Inhibitors--therapeutic use Prone Position--physiology Respiration, Artificial--methods Respiratory Distress Syndrome--physiopathology